Live Science on MSN6d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Inquirer on MSN2d
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health help
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...
BioSpace3d
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
Ketamine-derived nasal spray treating Phoenix patients with severe depression
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...
Badger Herald1d
Ketamine’s path to Medicaid coverage in Wisconsin marked by optimism, gathering acceptance
Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...
Imagine Healthcare Announces Expanded Access To Spravato - Now Available Without The Need For An Oral Antidepressant
( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Legal Disclaimer: ...
stocknews2d
3 Dividend Aristocrats With Consistent Payouts
Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...
pharmaphorum4d
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato ... through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...
pharmaphorum6d
J&J builds case for antidepressant Spravato with head-to-head trial
"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at ...